Rethinking creativity in dubbing
Translation Spaces · 16.06.2026 · 15 (1) · 10-28
DOI: 10.1075/ts.25002.spi ↗Kurz gefasst
Fachartikel in der Zeitschrift Translation Spaces, online erschienen am 11.09.2025. Verfasst von Giselle Spiteri Miggiani. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben.
Abstract (Originalsprache)
This article offers an academic reflection on creativity in dubbing, considering the emergence and growing presence of AI-dubs. It explores the concept of creativity as a possible key differentiator between human agency and machine-generated content ( Brandt 2023 ; Grassini and Koivisto 2024 ; Runco 2023 ). To this end, the article first examines creativity through a cross-disciplinary lens, establishing a broader conceptual theoretical framework and context for its definition and meaning. It then explores the creative practices associated with traditional studio-generated dubbing from both industry and academic perspectives, drawing insights from other fields that engage in constrained creative processes ( Baetens 2010 ; De Geest and Goris 2010 ; Krauth 2016 ; Wang 2009 ). Finally, it rethinks traditional creative practices in the context of AI-generated dubbed content, briefly summarizing preliminary research findings that compare studio-dubs and AI-dubs. The discussion focuses on how AI-dubbing technologies challenge established boundaries and norms, reshaping creative practices and the roles of dubbing practitioners — especially translators — and potentially influencing viewer perception.
Zitieren
APA
Miggiani, G. S. (2026). Rethinking creativity in dubbing. Translation Spaces, 15(1), 10-28. https://doi.org/10.1075/ts.25002.spi
Vancouver
Miggiani GS. Rethinking creativity in dubbing. Translation Spaces. 2026;15(1):10-28. doi:10.1075/ts.25002.spi
BibTeX
@article{Miggiani2026,
author = {Miggiani, Giselle Spiteri},
title = {Rethinking creativity in dubbing},
journal = {Translation Spaces},
year = {2026},
volume = {15},
number = {1},
pages = {10--28},
doi = {10.1075/ts.25002.spi}
}
EUVIMED